Healthcare
AbbVie’s JUVMO wins FDA approval for Parkinson’s disease
AbbVie expects the medicine to become available to US patients in October 2026.
Healthcare
Mirum and Incyte secure FDA approval for Atebrioz in FOP
The approval gives Mirum a new commercial product in the ultra-rare disease market while expanding treatment options for patients with...